Select regions whose content you would like to see
Generic drugs companies will be free to manufacture new products for non-EU markets during the period that supplementary protection certificates (SPCs) are in force under proposed new EU laws. 29 May 2018
Generic drug manufacturers should be able to manufacture medicines that are within the scope of supplementary protection certificates (SPCs) for export to non-EU markets during the time that those SPCs apply, Mylan's European president has said. 21 May 2018
This guide was updated in May 2017
This guide provides an outline of the UK's patent box regime for the taxation of intellectual property (IP) as it applies to companies and IP within the regime before 1 July 2016.
A patent is granted by a national patent office and will only give you monopoly rights in the country in which it is granted. There is no such thing as an international patent.
This guide is based on UK law. It was last updated in January 2012.
Sorting out disputes can take ages. Especially complicated ones, like patent disputes. To take a case to court, you will need lawyers – solicitors and barristers – and probably an expert to give evidence to back up your case. The ultimate outcome will be justice...
ANALYSIS: The UK's recent ratification of the Unified Patent Court (UPC) Agreement marked an important step towards a new system of unitary patent protection becoming operational. The process has been lengthy and complex and is not over yet. 01 May 2018
Patent lawyers across Europe have welcomed the news that the UK has ratified the Unified Patent Court (UPC) Agreement, but warned that the new system of unitary patent protection and dispute resolution it provides for will need to clear further hurdles before... 27 Apr 2018
Join My Out-Law
Already signed up to My Out-Law?
We see patents as a business tool. Our dedicated team of patent specialists advise clients from a range of industries on how to: secure market exclusivity for their inventions; access new markets through licensing technologies or challenging blocking patents; and, maximise the value of their innovation through strategic patent portfolio management and exploitation.
More about Patents
Partner - Head of IP & Life Sciences